BioLife Solutions (BLFS) Financials

$35.25

$-0.28 (-0.79%)

As on 04-Sep-2026 16:00EDT

Market cap

$1,724 Mln

Revenue (TTM)

$103 Mln

P/E Ratio

35.3

P/B Ratio

4.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	102.82	96.21	82.25	68.02	76.24	119.16
Cost of Revenue	36.52	34.10	28.58	26.70	29.33	82.11
Gross Profit	66.30	62.12	53.67	41.32	46.91	37.05
Operating Expenses	58.84	62.94	60.80	60.72	52.83	67.70
Operating Profit (EBIT)	7.45	-1.08	-7.13	-19.40	-5.92	-30.65
Other Income	--	--	--	--	--	--
Profit before Tax	8.07	-12.08	-11.43	-12.22	-4.85	-29.03
Provision for Tax	-42.38	0.05	-0.04	-0.06	-5.24	-20.12
Profit after Tax (Net Income)	50.45	-12.13	-20.18	-68.00	-139.81	-8.91
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-139.81	-8.38

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	420.00	371.89	348.91	337.66	364.19	478.05
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	13.54	11.02	17.84	32.87	41.46	33.54
Current Liabilities	13.95	22.98	32.73	42.18	44.58	42.70
Total Liabilities	461.44	405.88	399.49	412.71	450.23	554.29

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	312.30	269.32	250.73	292.11	311.78	428.20
Current Assets	135.20	136.56	148.76	120.60	138.45	126.09
Total Assets	461.44	405.88	399.49	412.71	450.23	554.29
Total Debt*	15.74	17.90	30.17	33.83	43.71	26.88
Net Current Assets	121.25	113.58	116.03	78.43	93.87	85.89

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	20.12	8.43	-12.50	-8.49	-4.84
Cash Flow from Investing Activities	--	-71.54	58.30	17.84	-58.12	-12.64
Cash from Financing Activities	--	-10.92	-6.78	10.59	16.32	-2.78
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	1.02	-0.25	-0.42	-1.56	-3.27	-0.21
Cash EPS ($)	--	-0.15	-0.24	-1.26	-2.88	-0.02
Adjusted Book Value ($)	--	7.64	7.26	7.74	8.51	11.47
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.41	0.18	-0.29	-0.20	-0.12
Free Cash Flow per Share ($)	--	0.01	0.11	-0.43	-0.44	-0.32

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-3.16	-5.38	-17.45	-30.63	-2.47
ROE (%)	12.74	-3.37	-5.88	-19.38	-33.20	-2.61
ROA (%)	11.50	-3.01	-4.97	-15.76	-27.84	-2.26
EBIT Margin (%)	6.03	-1.12	-8.67	-28.52	-14.00	-25.72
Net Margin (%)	49.06	-12.61	-24.54	-99.98	-183.38	-7.48
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	34.39	0.17	0.21	-0.11	-0.36	1.48
EBIT Growth (%)	146.48	84.84	63.25	-81.68	65.16	-819.84
Net Profit Growth (%)	1,012.22	39.90	70.32	51.36	-1,469.43	-434.01
EPS Growth (%)	965.62	0.41	0.73	0.52	-14.29	-3.64
Book Value Growth (%)	17.31	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	35.25	-96.97	-61.78	-10.43	-5.57	-174.36
Price / Book Value	4.13	3.16	3.57	2.10	2.14	3.25
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	322.55	306.49	765.35	-98.39	-245.42	-84.92
Close Price ($)	28.24	24.18	25.96	16.25	18.20	37.27
High Price ($)	30.00	29.62	28.88	26.89	38.69	60.67
Low Price ($)	17.86	19.10	14.50	8.92	10.40	28.15
Market Cap ($ Cr)	1,723.96	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.05	0.09	0.10	0.12	0.06
Short term debt to equity ratio	0.01	0.02	0.04	0.02	0.01	0.01
Current Ratio	9.69	5.94	4.54	2.86	3.11	2.95
Quick Ratio	7.14	4.63	3.66	1.83	2.32	2.29
Interest Coverage	13.22	-0.40	-9.92	-10.71	-15.54	-63.19

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	10.36	8.27	11.15	27.43	44.51	19.48
Asset Turnover	0.23	0.24	0.20	0.16	0.15	0.30
Receivable days	--	32.50	61.78	141.21	136.91	47.85
Inventory Days	--	316.92	463.03	536.01	393.85	88.85
Payable days	--	27.10	67.17	152.59	188.75	41.41
Cash Conversion Cycle	--	322.32	457.63	524.64	342.00	95.30

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.